The FDA is Taking a Big Risk on AI
CareTalk: Healthcare. Unfiltered.
00:00
Navigating AI Hallucinations in Healthcare Regulations
This chapter explores the challenges faced by the FDA in assessing artificial intelligence in healthcare, particularly the issue of AI-generated inaccuracies known as 'hallucinations.' It also addresses the complexities of maintaining data privacy and accuracy in the context of new drug approvals.
Transcript
Play full episode
